| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ... Autophagy 12 (1), 1-222, 2016 | 10681* | 2016 |
| Anisamide‐targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells R Banerjee, P Tyagi, S Li, L Huang International journal of cancer 112 (4), 693-700, 2004 | 325 | 2004 |
| The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR‐21 function by directly targeting its precursor D Bose, G Jayaraj, H Suryawanshi, P Agarwala, SK Pore, R Banerjee, ... Angewandte Chemie-International Edition 51 (4), 1019, 2012 | 197 | 2012 |
| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ... Taylor and Francis, 2016 | 168 | 2016 |
| Green synthesis and characterization of monodispersed gold nanoparticles: toxicity study, delivery of doxorubicin and its bio-distribution in mouse model S Mukherjee, S Sau, D Madhuri, VS Bollu, K Madhusudana, B Sreedhar, ... Journal of Biomedical Nanotechnology 12 (1), 165-181, 2016 | 164 | 2016 |
| Novel series of non-glycerol-based cationic transfection lipids for use in liposomal gene delivery R Banerjee, PK Das, GV Srilakshmi, A Chaudhuri, NM Rao Journal of medicinal chemistry 42 (21), 4292-4299, 1999 | 122 | 1999 |
| Design, synthesis, and transfection biology of novel cationic glycolipids for use in liposomal gene delivery R Banerjee, YV Mahidhar, A Chaudhuri, V Gopal, NM Rao Journal of medicinal chemistry 44 (24), 4176-4185, 2001 | 94 | 2001 |
| Lipid–protamine–DNA-mediated antigen delivery to antigen-presenting cells results in enhanced anti-tumor immune responses J Dileo, R Banerjee, M Whitmore, JV Nayak, LD Falo, L Huang Molecular Therapy 7 (5), 640-648, 2003 | 87 | 2003 |
| Haloperidol-associated stealth liposomes: a potent carrier for delivering genes to human breast cancer cells A Mukherjee, TK Prasad, NM Rao, R Banerjee Journal of Biological Chemistry 280 (16), 15619-15627, 2005 | 84 | 2005 |
| Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and … T Andey, G Sudhakar, S Marepally, A Patel, R Banerjee, M Singh Molecular pharmaceutics 12 (4), 1105-1120, 2015 | 74 | 2015 |
| 17β‐Estradiol‐associated stealth‐liposomal delivery of anticancer gene to breast cancer cells BS Reddy, R Banerjee Angewandte Chemie 117 (41), 6881-6885, 2005 | 73 | 2005 |
| Anchor dependency for non‐glycerol based cationic lipofectins: mixed bag of regular and anomalous transfection profiles RS Singh, K Mukherjee, R Banerjee, A Chaudhuri, SK Hait, SP Moulik, ... Chemistry–A European Journal 8 (4), 900-909, 2002 | 67 | 2002 |
| Cancer cell-selective promoter recognition accompanies antitumor effect by glucocorticoid receptor-targeted gold nanoparticle S Sau, P Agarwalla, S Mukherjee, I Bag, B Sreedhar, M Pal-Bhadra, ... Nanoscale 6 (12), 6745-6754, 2014 | 60 | 2014 |
| Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway MJ Lee, K Pal, T Tasaki, S Roy, Y Jiang, JY An, R Banerjee, YT Kwon Proceedings of the National Academy of Sciences 105 (1), 100-105, 2008 | 58 | 2008 |
| Process for synthesis of novel cationic amphiphiles containing N-hydroxyalkl group for intracellular delivery of biologically active molecules R Banerjee, PK Das, GV Srilakshmi, NM Rao, A Chaudhuri US Patent 6,333,433, 2001 | 54 | 2001 |
| Synthesis of 4, 6-disubstituted pyrazolo [3, 4-d] pyrimidine analogues: Cyclin-dependent kinase 2 (CDK2) inhibition, molecular docking and anticancer evaluation S Cherukupalli, B Chandrasekaran, RR Aleti, N Sayyad, ... Journal of Molecular Structure 1176, 538-551, 2019 | 49 | 2019 |
| Polyketide quinones are alternate intermediate electron carriers during mycobacterial respiration in oxygen-deficient niches A Anand, P Verma, AK Singh, S Kaushik, R Pandey, C Shi, H Kaur, ... Molecular cell 60 (4), 637-650, 2015 | 49 | 2015 |
| A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis S Sinha, S Roy, BS Reddy, K Pal, G Sudhakar, S Iyer, S Dutta, E Wang, ... Molecular cancer research 9 (3), 364-374, 2011 | 49 | 2011 |
| Non-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculin RK Thakur, VK Yadav, A Kumar, A Singh, K Pal, L Hoeppner, D Saha, ... Nucleic acids research 42 (18), 11589-11600, 2014 | 48 | 2014 |
| Cationic lipid-conjugated dexamethasone as a selective antitumor agent S Sau, R Banerjee European Journal of Medicinal Chemistry 83, 433-447, 2014 | 46 | 2014 |
Hari Krishnareddy Rachamalla, Ph.D.Mayo Clinic, Senior postdoctoral researcher在 mayo.edu 的电子邮件经过验证
